NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets

Nat Rev Cardiol. 2020 Mar;17(3):170-194. doi: 10.1038/s41569-019-0260-8. Epub 2019 Oct 7.

Abstract

Reactive oxygen species (ROS)-dependent production of ROS underlies sustained oxidative stress, which has been implicated in the pathogenesis of cardiovascular diseases such as hypertension, aortic aneurysm, hypercholesterolaemia, atherosclerosis, diabetic vascular complications, cardiac ischaemia-reperfusion injury, myocardial infarction, heart failure and cardiac arrhythmias. Interactions between different oxidases or oxidase systems have been intensively investigated for their roles in inducing sustained oxidative stress. In this Review, we discuss the latest data on the pathobiology of each oxidase component, the complex crosstalk between different oxidase components and the consequences of this crosstalk in mediating cardiovascular disease processes, focusing on the central role of particular NADPH oxidase (NOX) isoforms that are activated in specific cardiovascular diseases. An improved understanding of these mechanisms might facilitate the development of novel therapeutic agents targeting these oxidase systems and their interactions, which could be effective in the prevention and treatment of cardiovascular disorders.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / enzymology*
  • Cardiovascular Diseases / physiopathology
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Isoenzymes
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism*
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction* / drug effects

Substances

  • Enzyme Inhibitors
  • Isoenzymes
  • Reactive Oxygen Species
  • NADPH Oxidases